ArticleCancers2026

CHRNB4-Mediated Neuroactive Signaling Rewiring Drives Adaptive Resistance to BCL-2 Inhibition in Acute Myeloid Leukemia.

Hiroaki Koyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.